SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED.

• 1. 用于治疗其中涉及金属蛋白酶的病变的舒洛地昔 [P] . 中国专利： CN102883728A . 2013-01-16
• 2. 多奈必利作为治疗神经退行性疾病中的神经保护剂 [P] . 中国专利： CN113195452A . 2021-07-30
• 3. SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED. [P] . MX2012012285A . 2012-11-23

  机译： 在涉及金属蛋白酶的病原学治疗中使用苏必利定。

• 4. SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED [P] . 欧洲知识产权局专利： EP2560662B1 . 2017-06-07

  机译： Sulodexide用于治疗涉及金属蛋白酶的疾病

• 5. SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED [P] . PT2560662T . 2017-07-10

  机译： Sulodexide用于治疗涉及金属蛋白酶的疾病

• 1. Local inhibition of matrix metalloproteinases reduced M2 macrophage activity and impeded recovery in spinal cord transected rats after treatment with fibroblast growth factor-1 and nerve grafts [J] . Chuan-Wen Chiu, Wen-Hung Huang, Huai-Sheng Kuo, 中国神经再生研究（英文版） . 2018,第008期
• 2. Anesthetic Treatment in Operations of Small Pelvic Organs Pathology [J] . Taalaibek Atabaev, Zamirbek Arynov, Maksatbek Tashbaev, 麻醉学期刊（英文） . 2021,第012期
• 3. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved. [J] . Stenner M, Klussmann JP European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) . 2009,第3期
• 4. Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome. [J] . Jensen SA, Vainer B, Bartels A, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2010,第18期
• 5. Sulodexide for the extended treatment of venous thromboembolism [J] . Walenga Jeanine M., Fareed Jawed, Ramacciotti Eduardo International angiology: A journal of the International Union of Angiology . 2016,第6期
• 6. Targeted Delivery of Peptide-Based Matrix Metalloproteinase-2 (MMP-2) Inhibitor in Dual Sensitive Nanoparticles with Platelet Membrane Camouflage for Ischemic Limb Treatment [C] . Yu Dang, Ning Gao, Hong Niu, Society for Biomaterials annual meeting and exposition . 2019
• 7. Enhanced Activity of Matrix Metalloproteinase-9 Contributes to the Pathology of Fragile X Syndrome and can be Ameliorated with Minocycline Treatment [D] . Dansie, Lorraine E. 2011
• 8. Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis [O] . Giuseppe Pompilio, Davide Integlia, Joseph Raffetto, 2020
• 9. Sulodexide in the treatment of patients with early stages of COVID-19: a randomised controlled trial [O] . Alejandro J. Gonzalez-Ochoa, Joseph D. Raffetto, Ana G. Hernández, 2020

• 1. Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-β1,metalloproteinase-1,and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C [J] . Robert Flisiak ,Jerzy Jaroszewicz ,Tadeusz W Lapiski . 世界胃肠病学杂志：英文版 . 2005,第43期
• 2. Effect of lamivudine treatment on plasma levels of transforming growth factor β_1,tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B [J] . Robert Flisiak ,Haza Al-Kadasi ,Jerzy Jaroszewicz . 世界胃肠病学杂志：英文版 . 2004,第18期
• 3. Is omentectomy necessary in the treatment of benign or malignant abdominal pathologies?A systematic review [J] . Arif Atay ,Osman Nuri Dilek . 世界胃肠外科杂志:英文版(电子版) . 2021,第11期
• 4. 阿立哌唑、泰必利与可乐定透皮贴剂治疗儿童抽动障碍的对照研究 [C] . 邱鸣琦 ,陈燕惠 ,郑斌 . 中华医学会第十八次全国儿科学术会议 . 2013
• 5. 头针联合泰必利治疗抽动—秽语综合征的临床对照研究 [A] . 王丹 . 2018